Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | INPPL1 | O15357 | 7/20 | 0.50 |
| ▸ | INPP5A | Q14642 | 6/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | AKT1 | P31749 | 1/20 | 0.40 |
| ▸ | INPP5B | P32019 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28538119 | 0.87 | CES2 (0.50) | SRCBLMCA1CA2CYP2C19 | |
| SCHEMBL14608595 | 0.85 | BLM (0.81) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL1982061 | 0.84 | TSHR (0.52) | SRCBLMCA1CA2CYP2C19 | |
| SCHEMBL8386547 | 0.83 | SRC (0.52) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL329313 | 0.83 | SRC (0.75) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL21585511 | 0.83 | INPPL1 (0.50) | SRCBLMINPPL1INPP5ACA1 | |
| Ammonia Solution, Strong SCHEMBL10714477 | 0.81 | SRC (0.71) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL3083991 | 0.81 | SRC (0.54) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL10432958 | 0.81 | SRC (0.54) | SRCBLMINPPL1INPP5ACA1 | |
| SCHEMBL22356177 | 0.81 | SRC (0.54) | SRCBLMINPPL1INPP5ACA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117820636-B | Enzyme-responsive cytotoxic polyamino acid, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-05-24 | — | — | CN | claimed |
| CN-117820636-A | Enzyme-responsive cytotoxic polyamino acid, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-04-05 | — | — | CN | claimed |
| CN-107868187-B | Preparation method of low-hydration-heat polycarboxylate superplasticizer | 科之杰新材料集团有限公司 | 2020-05-08 | — | — | CN | claimed |
| CN-107987235-B | Preparation method of low-hydration-heat anti-cracking polycarboxylate superplasticizer | 科之杰新材料集团有限公司 | 2020-03-06 | — | — | CN | claimed |
| CN-107987228-B | Preparation method of low-hydration-heat early-strength polycarboxylate superplasticizer | 科之杰新材料集团有限公司 | 2020-03-06 | — | — | CN | claimed |
| CN-117820636-B | Enzyme-responsive cytotoxic polyamino acid, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-05-24 | — | — | CN | disclosed |
| CN-117820636-A | Enzyme-responsive cytotoxic polyamino acid, and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2024-04-05 | — | — | CN | disclosed |
| US-11254695-B2 | Soluble C5aR antagonists | CHEMOCENTRYX, INC. (US) | 2022-02-22 | — | — | US | disclosed |
| EP-3439658-B1 | SOLUBLE C5AR ANTAGONISTS | CHEMOCENTRYX INC (US) | 2021-11-24 | — | — | EP | disclosed |
| US-20200262853-A1 | SOLUBLE C5aR ANTAGONISTS | CHEMOCENTRYX, INC. | 2020-08-20 | — | — | US | disclosed |
| CN-107868187-B | Preparation method of low-hydration-heat polycarboxylate superplasticizer | 科之杰新材料集团有限公司 | 2020-05-08 | — | — | CN | disclosed |
| CN-107987235-B | Preparation method of low-hydration-heat anti-cracking polycarboxylate superplasticizer | 科之杰新材料集团有限公司 | 2020-03-06 | — | — | CN | disclosed |
| US-10329314-B2 | Soluble C5aR antagonists | CHEMOCENTRYX, INC. (US) | 2019-06-25 | — | — | US | disclosed |
| EP-3439658-A2 | SOLUBLE C5aR ANTAGONISTS | ChemoCentryx, Inc. (US) | 2019-02-13 | — | — | EP | disclosed |
| US-20190010177-A1 | SOLUBLE C5aR ANTAGONISTS | CHEMOCENTRYX, INC. | 2019-01-10 | — | — | US | disclosed |
| WO-2017176620-A2 | SOLUBLE C5aR ANTAGONISTS | CHEMOCENTRYX, INC. (US) | 2017-10-12 | — | — | WO | disclosed |
| US-20170283446-A1 | SOLUBLE C5aR ANTAGONISTS | CHEMOCENTRYX, INC. | 2017-10-05 | — | — | US | disclosed |
| WO-2015140575-A1 | ENZYME DETECTION METHOD | ATLAS GENETICS LIMITED (GB) | 2015-09-24 | — | — | WO | disclosed |
| EP-1885875-A2 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORPORATION (US) | 2008-02-13 | — | — | EP | disclosed |
| WO-2006130551-A2 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200262853-A1 | SOLUBLE C5aR ANTAGONISTS | C5AR1, C3AR1, C5AR2 | SRC 1195/4885BLM 3869/4885INPPL1 2671/4885 |
| US-20170283446-A1 | SOLUBLE C5aR ANTAGONISTS | C5AR1, C3AR1, C5AR2 | SRC 1195/4885BLM 3869/4885INPPL1 2671/4885 |
| US-20190010177-A1 | SOLUBLE C5aR ANTAGONISTS | C5AR1, C3AR1, C5AR2 | SRC 1195/4885BLM 3869/4885INPPL1 2671/4885 |
| US-10329314-B2 | Soluble C5aR antagonists | C5AR1, C3AR1, C5AR2 | SRC 1195/4885BLM 3869/4885INPPL1 2671/4885 |
| US-11254695-B2 | Soluble C5aR antagonists | C5AR1, C3AR1, C5AR2 | SRC 1195/4885BLM 3869/4885INPPL1 2671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.